AI Chatbots for Vaccine Hesitancy

Penn Engineering’s trial found a GPT-4o chatbot produced immediate gains in parents’ intention to vaccinate comparable to standard public-health materials, but the chatbot effect waned by day 45 while written materials retained impact longer. Rising distrust in public-health institutions increases the need to evaluate chatbots by both immediate persuasion and persistence across segments.

• Penn trial: GPT-4o chatbot increased immediate vaccination intention roughly equal to written materials, but the effect waned by day 45.
• Survey baseline: n = 2, 205 U.S. adults showed trust in the CDC ≈50% (down from ≈75% in 2022–2025), signaling higher reliance on alternative channels.
• Recommendation: treat chatbots as an experimental channel, pair bots with durable assets (downloadables, appointment links), and measure persistence at 30–90 days.

Penn Engineering found a GPT-4o-based chatbot produced immediate gains in parents' intention to vaccinate (HPV) that matched standard public-health materials, but the chatbot effect waned by day 45 and written materials retained impact longer. Read the original coverage at TechTarget.

• Study headline: chatbots can move intent short-term but may not outlast static, science-backed pages.
• Context: rising distrust, a 2, 205-person survey shows CDC trust fell to ≈50% (from ≈75% in 2022–2025).

Penn researchers compared an interactive GPT-4o chatbot to standard public-health materials, and brief chatbot interactions increased parents' vaccine intention roughly as much as reading written materials, but at a 45-day follow-up the written-materials group reported higher sustained intention than the chatbot group.

• Immediate effect: chatbot ≈ written materials for intention-to-vaccinate.
• Durability: written materials showed longer-lasting effects at 45 days.
• Risks noted: chatbots can hallucinate and be manipulated, and access and digital literacy vary across communities.

Run this checklist in a 2–6 week pilot to compare chatbot versus written materials and measure durability.

• 1) Define outcomes: immediate intent, 30/45/90-day intent, and concrete actions such as appointment scheduled.
• 2) Build matched prompts and control materials that present the same facts and tone.
• 3) Collect multi-format data: chat logs, survey responses (pre/post), and short qualitative interviews (n per arm).
• 4) Ingest everything into Evidano: transcripts, spreadsheets, and logs.
• 5) Auto-code and refine: use AI-assisted coding, import your codebook, then iterate with manual QA.
• 6) Run cross-segment analyses: compare persistence by trust quintile, parent status, and digital-literacy groups.
• 7) Deliver decision-ready outputs: visual co-occurrence maps, top-supporting quotes, and an action memo recommending whether to scale chatbots or reinforce written assets.

AI chatbots for vaccine hesitancy are a promising channel for short-term persuasion, but persistence and equity questions remain, so combine experimental rigor with qualitative depth to discover where bots add real value and for whom.

• Ready to run a reproducible pilot? Upload your transcripts and survey sheets to Evidano and get thematic, frequency, and cross-segment analyses in hours, not weeks, or Try Evidano for free.
• Original reporting: TechTarget